Biomolecular Life Holdings Steps Up with Acquisition Plans for Dr. Dacon's Medical Practice

Biomolecular Life Holdings Takes a Major Step Forward



November 17, 2026 | Miami and Bogotá
Biomolecular Life Holdings, Inc., a holding firm focused on health and wellness through biomolecular solutions, has announced plans to acquire Dr Dacon Medicina Biológica SAS, the medical practice of expert Dr. David Contreras in Bogotá, Colombia. This ambitious acquisition aims to enhance Biomolecular Life's integrated health platform, merging cutting-edge biomolecular therapy with its range of wellness products and services.

The acquisition also encompasses the property of the clinic situated in the prestigious Santa Bárbara district, conveniently located across from the renowned Fundación Santa Fe de Bogotá University Hospital. This move represents a strategic enhancement to BIOM’s infrastructure, providing a dedicated healthcare setting that aligns with its focus on biomolecular nutrition and innovative wellness technologies.

Significance of the Acquisition


This acquisition is not just about expanding the company’s portfolio; it reflects a crucial part of BIOM's strategy to establish a comprehensive integrated biomolecular health platform. Following a letter of intent to acquire Biomolecular Life LLC, a company specializing in nutritional supplements for both humans and pets, this latest announcement underscores BIOM's commitment to building a holistic approach to health that intertwines clinical expertise and wellness offerings.

Dr. Dacon would effectively serve as the clinical wing of Biomolecular Life, providing medical oversight and expertise essential for implementing biomolecular therapy programs, particularly those set to launch at the Llanogrande retreat planned for 2028.

Investment Highlights


BIOM's management believes that the prospective acquisition brings several noteworthy advantages:
- Prime Medical Real Estate: The Santa Bárbara clinic not only offers valuable property assets but also positions the practice within a top medical precinct, enhancing the company's long-term sustainability.
- Established Clinical Practice: With over two decades of experience, Dr. Contreras has cultivated a medical practice that extends its service reach across twelve countries.
- Renowned Leadership in Medicine: Dr. Contreras is recognized for his expertise in biomolecular therapy, having trained in Germany and conducted crucial research in cell reprogramming.
- Vertically Integrated Model: The merger aims to integrate various sectors of health and wellness, uniting medical services, product sales, and hospitality ventures seamlessly under one roof.
- Diverse Revenue Streams: New programs for medical consultations and therapy will bolster BIOM’s revenue base alongside its product offerings.
- Growing Market Potential: The global wellness economy is on an upward trajectory, projected to grow from $6.8 trillion in 2024 to nearly $9.8 trillion by 2029, presenting ample opportunities for BIOM's initiatives.
- Foundation for Llanogrande: Dr. Dacon’s clinic will provide the essential clinical frameworks needed for the successful operation of the Biomolecular Wellness Spa.

Dr. David Contreras: A Leader in Biomolecular Medicine


Dr. David Contreras brings a wealth of experience and recognition in the field of biomolecular therapy and regenerative medicine. His medical journey began in the military serving the Colombian Battalion, where he was involved in peacekeeping. He holds a medical degree from Nueva Granada Military University and has extensive clinical and research experience that includes academic training in painful rehabilitation while serving the Colombian Armed Forces.

Dr. Contreras trained in biomolecular therapy in Stuttgart, Germany, expanding his influence through collaborations with multiple international health care pioneers and scientific institutions. His approaches have benefited countless patients from various countries, enhancing their access to advanced medical solutions.

Looking Ahead


The integration of Dr. Dacon’s expertise into Biomolecular Life Holdings is anticipated to be a pivotal moment for the company. As President and CEO Jessika Wiesner stated, this partnership not only advances their vision but also significantly enhances the medical and therapeutic offerings provided to a broader audience. Dr. Contreras envisions this collaboration as a pathway to expand personalized healthcare services on an international level, further promoting preventive medicine and innovative therapeutic practices.

As the acquisition progresses, pending regulatory clearances, and agreement finalizations, Biomolecular Life is set to redefine the standards of integrated health solutions and wellness practices through its innovative approaches and expert collaborations.

For comprehensive information about Biomolecular Life Holdings and updates on this acquisition, visit www.biomolecularlifeinc.com.

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.